Health / Medical Topics

    Plasmacytoid Dendritic Cell Vaccine

    A whole cell vaccine derived from a distinct subset of dendritic cells (DCs) with a plasma cell-like morphology that exhibits immunomodulating activity. Plasmacytoid dendritic cells (pDCs) express a characteristic set of surface markers, such as CD123 (interleukin-3 receptor alpha chain), BDCA-2 (blood dendritic cell antigen 2; CD303) and BDCA-4 (CD304), as well as intracellular toll-like receptors 7 and 9. Upon stimulation, the activated pDCs produce substantial amounts of interferon (IFN) alpha, and to a lesser degree IFN-beta, as well as other cytokines and chemokines, such as tumor necrosis factor alpha and interleukins 1, 6 and 8. In addition, these pDCs, directly or indirectly stimulate T-cells, B-cells and natural killer cells. This may potentially lead to increased immunity against tumor cells. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    An early post-transplant lymphoproliferative lesion characterized by plasmacytic proliferation and architectural preservation of the involved tissues. It often regresses either spontaneously…
    Having to do with plasma cells (a type of white blood cells).
    A type of immune cell that makes large amounts of a specific antibody. Plasmacytes develop from B cells that have been…
    A plasmablastic lymphoma arising in the oral cavity, usually associated with HIV infection.
    An aggressive diffuse large B-cell lymphoma usually arising in the setting of HIV infection and characterized by the presence of large neoplastic…
    The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a plasma…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact